✕
Login
Register
Back to News
Phase 3 ATLAS-UC induction-Only Study Met Primary Endpoint
Benzinga Newsdesk
www.benzinga.com
Positive 79.5%
Neg 0%
Neu 0%
Pos 79.5%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment